DNMT1 and acute myeloid leukemia: Importantly, it has demonstrated a high efficacy in AML xenograft models, presenting an exciting opportunity for clinical implementation and promise as a valuable tool that could be used to understand the mechanism of action of DNMT1 during AML progression [108].